Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.70 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.56 |
| ▸ | DRD4 | P21917 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 12/20 | 0.54 |
| ▸ | CA1 | P00915 | 12/20 | 0.54 |
| ▸ | CA2 | P00918 | 12/20 | 0.54 |
| ▸ | CA4 | P22748 | 2/20 | 0.54 |
| ▸ | CA5A | P35218 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 10/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12233107 | 1.00 | PKM (0.70) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL3821203 | 1.00 | PKM (0.70) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL13086539 | 1.00 | PKM (0.70) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL26443905 | 1.00 | PKM (0.70) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL12083331 | 1.00 | PKM (0.70) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL7152987 | 1.00 | PKM (0.70) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL3817357 | 0.98 | PKM (0.68) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL6947077 | 0.93 | PKM (0.62) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL6951810 | 0.93 | PKM (0.62) | PKMNR3C1FYNADRA2AADORA3 | |
| SCHEMBL14363903 | 0.91 | PKM (0.61) | PKMNR3C1FYNADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090176970-A1 | Preparation of Thiosugars and Their Use | GLYCOFORM LIMITED (GB) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176970-A1 | Preparation of Thiosugars and Their Use | TST, TREH, FUT6 | PKM 3129/4885NR3C1 3031/4885FYN 4184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.